ENOS anticorps (Ser1177)
Aperçu rapide pour ENOS anticorps (Ser1177) (ABIN2259911)
Antigène
Voir toutes ENOS (NOS3) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1156-1183, Ser1177
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- eNos (S1177) (NOS3, Nitric oxide synthase, endothelial, Constitutive NOS, EC-NOS, Endothelial NOS, NOS type III)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- KLH-conjugated synthetic peptide mapping to a fragment of residues within amino acids 1156-1183 of human eNos, UniProt Accession #P29474. Species sequence homology: bovine, mouse, porcine, rat
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- ENOS (NOS3) (Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3))
-
Autre désignation
- eNos
-
NCBI Accession
- NP_001153582, NP_000594, NP_001153581
-
UniProt
- P29474
-
Pathways
- ACE Inhibitor Pathway, Regulation of Systemic Arterial Blood Pressure by Hormones, Cellular Response to Molecule of Bacterial Origin, Myometrial Relaxation and Contraction, Signaling Events mediated by VEGFR1 and VEGFR2, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling
Antigène
-